Released Apr 16, 2012, after the close
10-K filed Apr 16, 2012, 107 days after period end · 0001193805-12-000689
Q4 2011 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$6.65M$6.65M derivedno prior Q4 2010 on file+6.5% vs Q3 2011
Net Income$1.99M$1.99M derivedno prior Q4 2010 on fileN/M vs Q3 2011
EPS, diluted—Not derived. Share counts vary by quarter.
Gross Profitderived$2,328,141—
Operating Incomederived$1,020,400—
Operating Cash Flowderived$731,202−55.6%
Free Cash Flowderived$506,816−68.6%
Margins · derived
Gross margin35.0%
Operating margin15.3%
Net margin29.9%
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-K.
Same quarter
| Metric | Q4 2011dderived from reported figures | Q4 2010dderived from reported figures |
|---|---|---|
| Revenue | $6.65M | — |
| Net Income | $1.99M | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Tanke Biosciences Corp · CIK 1452011 · Engraved from SEC EDGAR